Irwin Naturals To Acquire Serenity Health
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) signed a binding, arms-length, agreement to acquire Serenity Health, LLC in Louisville, Kentucky, on November 25, 2022.
Numinus Wellness Inc.’s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022.
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here’s The Latest
A psychedelics R&D biotech company, known for providing novel treatments for addictions, is opening a new ketamine clinic.
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness Corp., has entered into a joint venture agreement with Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience and more than 30.000 patients treated, specializing in multidisciplinary medical specialties.
Psyched: Musk’s Empathy Tweets, Psychedelics In Congress, Oregon’s Opt-Outs, MAPS’ MDMA Trial And More
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy
Oregon Psychedelics Companies Set The Stage For Future Regulations Of Natural Medicine Centers
Silo Wellness (OTCQB: SILFF) aims to establish a psilocybin center retreat in the New Frontier Ranch in Jackson County seems closer to becoming a reality.
Congress Is Shaking It Up On Cannabis Reform, Some Wish They’d Started Sooner But Better Late Than Never
As the lame-duck Congress scurries to get its ducks in order before they get pushed out of the nest, lawmakers are doing their best for cannabis and psychedelics reform.
Here’s what happened in the past several days.
Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS’ Published Results
(Part two of a four-part series)
See previous story in this series: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes
Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial
Psychedelics company Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Science Inc. has entered into a research services agreement with Canadian-based biotech Nova Mentis Life Science Corp.